Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Toxicology and Pharmacology of Drugs Developed for Cancer, AIDS, and
McCormick, David
Search 215 grants from David McCormick
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Proteomic and Transcriptional Analysis of Cilia-Dependent Dopamine Receptor 1 Signaling
Role of HDAC6 in platinum resistance of non-small cell lung cancer
Lipase in Cocaine Cue Associations in the Amygdala
mRNA Targets of the alpha CP RNA-binding Proteins
2-Dimensional Ultrasonic Imaging of the Microcirculation
Recently added grants:
Safety Promotion through Early Event Detection in the Elderly (SPEEDe)
Regulation of hematopoiesis by ribosomal protein paralogs
Tcr Parameters of Treg Function in Autoimmunity
The effect of Strongyloides stercoralis on HTLV-1 disease progression
Organ-specific autoimmunity resulting from two genetic defects in tolerance
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM42202-13-0-0
Application #
7543410
Study Section
Project Start
2004-04-01
Project End
2011-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
$1,272,233
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Toxicology and Pharmacology of Drugs for Cancer
/ Iit Research Institute
$1,741,870
NIH 2007
N01 CA
Preclinical Toxicology and Pharmacology of Drugs Developed for Cancer, AIDS, and
McCormick, David /
$1,272,233
NIH 2007
N01 CA
Preclinical Toxicology and Pharmacology of Drugs for Cancer
/
Comments
Be the first to comment on David McCormick's grant